There are various private clinics in Mauritius, however public hospitals are entirely free. The healthcare system of Mauritius consists of 19 private clinics and hospitals, 30 medical labs, two public district hospitals, four specialized public hospitals, five large regional public hospitals, and two cardiac centers. There were 4,498 beds available in public and private establishments as of the end of 2019.
Advantages:
Health care is well-developed in Mauritius. Public health organizations serve around 73% of the population's healthcare requirements, while the private sector serves 27% of them. 85 percent of annual total mortality in Mauritius is caused by non-communicable illnesses include chronic respiratory diseases, cancer, diabetes, and cardiovascular disorders.
In October 2019, a brand-new ENT facility was opened with financing of about $23 million from the Indian government. A brand-new cancer hospital debuted in February 2021. The finance minister stated in the speech outlining the 2020-2021 budget that work on a new eye hospital and a teaching hospital will start in October 2020 and early 2021, respectively.
There may be chances to establish:
Specialized facilities for the study and treatment of diabetes; specialized facilities for the care of the aged and rehabilitation medicine;
Clinics for dental surgery and dentofacial orthopedics; specialist facilities for cutting-edge treatments including stem-cell therapies; clinics for plastic and reconstructive surgery; and convalescence and pain clinics offering specialized care to patients suffering from acute and chronic diseases.
There may be other chances to establish:
Clinics for plastic and reconstructive surgery; Clinics for dental and dentofacial orthopedics; and Convalescence and pain clinics offering specialized care to patients suffering from acute and chronic conditions. Specialized centers for diabetes research and treatment. Specialized centers for elderly care and rehabilitative medicine.
Over the past few years, the medical device manufacturing sector has also shown consistent expansion. Leading medical device manufacturers, primarily from France and Germany, have established facilities in Mauritius as a result of the privileged market access that this island nation has with the EU. Angioplasty catheters, stents, cardiovascular and oncology implants, synthetic skin, ophthalmology implants, bone implants and replacements, orthopedic implants, and dental implants are the primary products produced in Mauritius for export. The government provides several incentives to entice more medical device manufacturing companies, such as tax holidays for eight years, a three percent corporate tax on export profits, a value-added tax on raw materials reimbursed on exports, a fifteen percent investment tax credit over three years for investments in hi-tech machinery, and a rebate for air and sea freight for exports.
The government announced additional incentives in the 2021-2022 budget to promote the development of manufacturing facilities for pharmaceutical and medical devices, including exemptions from registration duty and land transfer tax, exemptions from land conversion tax, and an exemption from the construction-related value-added tax (VAT). A premium investor certificate, together with a complete tax credit on the expenses of acquiring patents for biotechnology and pharmaceutical enterprises, would be advantageous to businesses involved in the production of medical equipment and medicines. The tax rate for businesses operating in the healthcare, biotechnology, and pharmaceutical industries will be reduced to 3% from 15%.
Комментарии